Cure Alzheimer's Fund Cure Alzheimer's Fund

OUR MISSION

Cure Alzheimer’s Fund is a nonprofit organization dedicated to funding research with the highest probability of preventing, slowing, or reversing Alzheimer’s disease.

OUR IMPACT

Since our founding in 2004, our unwavering focus has been providing research grants to the world’s leading scientists researching Alzheimer’s disease.

Cure Alzheimer’s Fund has contributed more than $270,000,000 to Alzheimer’s research. Projects we have funded have yielded important breakthroughs, developing a deeper understanding of Alzheimer’s disease, and getting closer to a cure.

Learn about our research

 

 

OUR MODEL

In forming Cure Alzheimer’s Fund, our founders created the only nonprofit organization dedicated exclusively to finding a cure for the disease. Guided by their vision, we encourage our scientists to pursue the wild ideas and take the bold risks we believe lead to breakthroughs.

 

Microscope Icon
Fund high-risk, high reward research with the potential to accelerate a cure or disease-modifying treatment.
Require funded researchers to collaborate and share data.
Identify and support investigators who will contribute to the field’s knowledge base with bold hypotheses and well-crafted experimental plans.
Fund scientists quickly throughout the year by eliminating red tape and streamlining application requirements.
Utilize teams of leading scientists to guide scientific direction, review grant proposals and assess the research portfolio.
Prioritize returns measured in scientific knowledge, not potential profits.
Our Board of Directors, Trustees, and Sustaining Partners empower CureAlz operations and allow 100% of your gift to support our research program.

 

OUR FOUNDERS

Jeff Morby, Jacqui Morby, Henry McCance, and Phyllis Rappaport saw the need for a new approach to Alzheimer’s research. Frustrated with the slow pace of research about the disease, our founders applied their experience in venture capital and corporate startups to build an organization specifically designed to accelerate research, make bold bets, and end the disease.

Jeff Morby
Jacqui Morby
Henry McCance
Phyllis Rappaport

 

 

Our Research

Our People

2025 Annual Report

Reports

Join Our Team